---
slug: tesamorelin
title: "tesamorelin"
kind: standard
status: published
hash: f42477efae1eb01764cedf077b26756087d19731132dddfd929ae82672a0221e
created: 2026-06-29T17:02:16.154Z
updated: 2026-10-08T11:49:45.043Z
summary: "Evidence is being populated by Grok web"
tags: []
above: []
below: []
adjacent: []
nested: []
---
# tesamorelin

*Evidence is being populated by Grok web*

## Overview
Evidence is being populated by Grok web search.

## Facts

```json
{
  "converted_from": "markdown",
  "original_updated": "2026-06-29T17:02:16.853Z",
  "register": "standard",
  "category": null
}
```

## Sources

1. [Body composition, hepatic fat, metabolic, and safety outcomes of Tesamorelin, a GHRH analogue, in HIV-associated lipodystrophy: A meta-analysis of randomized controlled trials](https://pubmed.ncbi.nlm.nih.gov/41545261/) — “Tesamorelin improves body composition, hepatic fat, lean body mass, and IGF-1 levels in HIV-associated lipodystrophy, without serious side effects” (sha256 e4c4dcf3f8122a9f)
2. [Effects of Tesamorelin on Neurocognitive Impairment in Persons With HIV and Abdominal Obesity](https://pubmed.ncbi.nlm.nih.gov/39813152/) — “Tesamorelin, a growth hormone-releasing hormone, reduces AO and increases IGF-1, suggesting that it might mitigate NCI in people with HIV and viral suppression.” (sha256 48e2697d62afc5ee)
3. [Tesamorelin as an Adjunct to Exercise for Improving Physical Function and Muscle Health in Adults With HIV (TRIUMPH Trial)](https://clinicaltrials.gov/study/NCT06554717) — “The goal of this clinical trial is to learn whether the medication tesamorelin will improve physical function and muscle health in adults with HIV when combined with exercise.” (sha256 1d99711e3f24dcd2)